| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/16/1995 | WO1995004531A1 Fibrinogen receptor antagonists |
| 02/16/1995 | WO1995004530A1 Endothelin receptor antagonists |
| 02/16/1995 | WO1995004529A1 Composition for treatment of hangovers |
| 02/16/1995 | WO1995004528A2 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE |
| 02/16/1995 | WO1995004527A1 Gelatin capsules containing a highly concentrated acetaminophen solution |
| 02/16/1995 | WO1995004526A1 Lupane triterpenoid derivatives |
| 02/16/1995 | WO1995004525A2 Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection |
| 02/16/1995 | WO1995004522A1 Spray formulation having a cooling effect |
| 02/16/1995 | WO1995004520A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
| 02/16/1995 | WO1994023028A3 Modified oligonucleotides having improved anti-influenza activity |
| 02/16/1995 | DE4327147A1 Pharmaceutical composition which, besides the active ingredient, contains a mixture of gelatins which differ in solubility |
| 02/16/1995 | DE4327089A1 Composition for the treatment of allergic disorders of the airways |
| 02/16/1995 | DE4326675A1 Use of a combination of folic acid, vitamin B6 and vitamin B12 for preventing nerve degeneration disorders and senile dementia |
| 02/16/1995 | CA2169291A1 Lupane triterpenoid derivatives |
| 02/16/1995 | CA2169277A1 C-22 ring stabilized rapamycin derivatives |
| 02/16/1995 | CA2169164A1 Low flux transdermal potent drug delivery system |
| 02/16/1995 | CA2168884A1 Therapeutic formulation |
| 02/16/1995 | CA2168853A1 Hydroisoquinoline derivatives |
| 02/16/1995 | CA2168791A1 Matrix metalloprotease inhibitors |
| 02/16/1995 | CA2168750A1 Condensed indole derivatives as 5-ht4-receptor antagonists |
| 02/16/1995 | CA2168668A1 Aza-5,5-fused heterocyclic acids as leukotriene antagonists |
| 02/16/1995 | CA2168581A1 Fibrinogen receptor antagonists |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/16/1995 | CA2168425A1 Cosmetic compositions |
| 02/16/1995 | CA2167154A1 Gastrin and cck receptor ligands |
| 02/16/1995 | CA2146547A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
| 02/16/1995 | CA2145178A1 Substituted kynurenines, a process for their preparation, and use as medicaments |
| 02/16/1995 | CA2142349A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 02/15/1995 | EP0638587A1 Salmycins, a process for their preparation and their use as a pharmaceutical |
| 02/15/1995 | EP0638586A2 Nucleoside derivatives and methods for producing them |
| 02/15/1995 | EP0638585A1 5-o-desosaminylerythronolide a derivative |
| 02/15/1995 | EP0638584A1 5-o-desosaminylerythronolide a derivative |
| 02/15/1995 | EP0638583A1 Aminosugar active substances, a process for their preparation and use as pharmaceuticals |
| 02/15/1995 | EP0638581A1 Phosphonic diester derivative |
| 02/15/1995 | EP0638574A1 Oxime derivatives of cephalosporanic structure and compounds for their preparation |
| 02/15/1995 | EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them |
| 02/15/1995 | EP0638569A1 Bicyclic nitrogenous compound |
| 02/15/1995 | EP0638568A1 Substituted piperazines, their process of preparation and the pharmaceutical compositions containing them |
| 02/15/1995 | EP0638562A1 Anthraquinone derivatives useful in the treatment of cancer and osteoartritis |
| 02/15/1995 | EP0638558A1 Crystalline modification of 2,4-dioxo-6-methyl-1,2,3,4-tetrahydropyrimidine, method of obtaining the same and a pharmaceutical preparation based on it |
| 02/15/1995 | EP0638556A1 Medicaments containing 1-Thiocarbamoyl-5-hydroxy pyrazoles and their use as agents for the treatment of septic shock |
| 02/15/1995 | EP0638554A1 Process for producing a N-phenyl-N-(4-piperidinyl) amide derivative |
| 02/15/1995 | EP0638553A1 Carboxylic acid amides having a terminal carboxylic acid group as aggregation inhibiting drugs |
| 02/15/1995 | EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 02/15/1995 | EP0638540A1 Pharmaceutical anthracene-2-carboxylic acid derivatives |
| 02/15/1995 | EP0638321A1 Ipriflavone and pharmaceutical compositions and their use for bone defect substitution |
| 02/15/1995 | EP0638317A1 Pharmaceutical composition |
| 02/15/1995 | EP0638312A1 Dermatologic preparation composition containing isocarbacyclin as active ingredient |
| 02/15/1995 | EP0638311A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 02/15/1995 | EP0638310A1 Pharmaceutical compositions containing ifetroban |
| 02/15/1995 | EP0638309A1 Substances inhibiting proteic adp ribosilation suitable to prevent the diabetes mellitus complications |
| 02/15/1995 | EP0638119A1 Chimeric receptor genes and cells transformed therewith |
| 02/15/1995 | EP0638101A1 Synthetic melanin |
| 02/15/1995 | EP0638090A1 17$g(a) AND 17$g(b)-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0638084A1 Substituted phosphonates, the processes for their preparation and pharmaceutical compositions containing them |
| 02/15/1995 | EP0638082A1 Macrocyclic immunomodulators |
| 02/15/1995 | EP0638081A1 Delta opioid receptor-selective benzylidene-substituted morphinans for the treatment of alcohol abuse |
| 02/15/1995 | EP0638080A1 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
| 02/15/1995 | EP0638079A1 Deazaaminopterins for treatment of inflammation |
| 02/15/1995 | EP0638078A1 Avermectin difluoro derivatives |
| 02/15/1995 | EP0638075A1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 02/15/1995 | EP0638073A1 1-piperazino-1,2-dihydroindene derivatives |
| 02/15/1995 | EP0638061A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness |
| 02/15/1995 | EP0637965A1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 02/15/1995 | EP0637961A1 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors |
| 02/15/1995 | EP0637960A1 SUBSTITUTED INDOLIZINO 1,2-b]QUINOLINONES |
| 02/15/1995 | EP0637959A1 Soluble analogs of probucol |
| 02/15/1995 | EP0637957A1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases. |
| 02/15/1995 | EP0637956A1 Use of remacemide for the treatment of parkinson's disease |
| 02/15/1995 | EP0637915A1 Compositions and methods for regulating il-6 production in vivo |
| 02/15/1995 | EP0627900A4 Use of injectable biomaterials for the repair and augmentation of the anal sphincters. |
| 02/15/1995 | EP0540544B1 Benzoic acid substituted derivatives having cardiovascular activity |
| 02/15/1995 | EP0425507B1 Compositions and methods for treating skin conditions and promoting wound healing |
| 02/15/1995 | EP0423366B1 Phospholipid derivatives |
| 02/15/1995 | EP0394484B1 Benzothiadiazepine derivatives |
| 02/15/1995 | EP0344288B1 Method of inhibiting the activity of leukocyte derived cytokines |
| 02/15/1995 | EP0339046B1 Leukotriene b 4 analogs |
| 02/15/1995 | CN1098721A Condensed quinolyl-dihydropyridines, processes for their preparation and their use in medicaments |
| 02/15/1995 | CN1098715A 1H-indole-3-acetamide spla2 inhibitors |
| 02/15/1995 | CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors |
| 02/15/1995 | CN1098638A Detoxicating mixture |
| 02/15/1995 | CN1098624A Pharmaceutical preparation containing L-aspartate or L-asparagine for preventing ethanol toxicity, and process for preparation thereof |
| 02/15/1995 | CN1098623A Compound dicloxacillin dispain preparation |
| 02/15/1995 | CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives |
| 02/14/1995 | US5389684 Naphthalene carboxamides |
| 02/14/1995 | US5389683 Useful in treating or preventing a disorder of the melatoninergic system |
| 02/14/1995 | US5389681 Parenteral solutions for diclofenac salts |
| 02/14/1995 | US5389679 Exposing tissue to effective amount of lactic acid or a salt thereof |
| 02/14/1995 | US5389678 Soluble aluminum carboxylate bathing preparation |
| 02/14/1995 | US5389677 Method of treating wrinkles using glycalic acid |
| 02/14/1995 | US5389676 A water in oil or oil in water antibacterial emulsion comprising betaines and amine oxides, hydrophobic materials, water soluble nonionic, cationic surfactants; stability, bactericides, antiseptics; soap, shampoo, wound healing agent |
| 02/14/1995 | US5389675 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
| 02/14/1995 | US5389670 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 02/14/1995 | US5389668 Thiochroman compounds |
| 02/14/1995 | US5389666 Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 02/14/1995 | US5389664 Administering benzimidazole compounds to inhibit at pase activity |
| 02/14/1995 | US5389660 Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists |
| 02/14/1995 | US5389659 C-linked pyrazole derivatives |
| 02/14/1995 | US5389657 Administering as a glutathione stimulator, 2-oxothiazolidine-4-carboxylate; defense to egg/embryo peroxidation |